UTILIZATION OF STEM CELL THERAPY AS A NEW APPROACH TO OVERCOME REPRODUCTIVE DISEASES IN WOMEN
Downloads
The human body contains approximately 37.2 trillion cells, each specialized to perform specific functions within tissues and organs. Stem cells, particularly mesenchymal stem cells (MSCs), have emerged as a promising therapeutic option for various medical conditions due to their regenerative and differentiation capabilities. Female infertility, which significantly impacts quality of life, often results from reproductive disorders such as premature ovarian failure (POF), polycystic ovary syndrome (PCOS), endometriosis, Asherman syndrome, and preeclampsia. Conventional treatments like hormone therapy are limited by long-term risks, including heart disease and cancer, while assisted reproductive technologies are hindered by ethical, safety, and financial concerns. This review explores MSC-based therapies as innovative alternatives for addressing female reproductive disorders. MSCs demonstrate potential in regenerating ovarian cells, restoring hormonal balance, and repairing uterine tissue. For POF, MSC therapy replenishes ovarian cells, improves hormone levels, and restores function. In PCOS, MSCs reduce inflammation and fibrosis while enhancing ovarian function. Endometriosis management benefits from MSCs' ability to repair endometrial damage and improve uterine receptivity. MSCs also show efficacy in reducing fibrosis and increasing vascularization in Asherman syndrome and repairing placental damage in preeclampsia by mitigating oxidative stress and inflammation. This review synthesizes findings from recent studies to highlight MSCs' role in advancing gynecological medicine, presenting them as a safe, effective, and sustainable therapeutic approach for treating infertility and enhancing reproductive health.
Artemova, D., Vishnyakova, P., Gantsova, E., Elchaninov, A., Fatkhudinov, T. and Sukhikh, G. (2023), “The prospects of cell therapy for endometriosis”, Journal of Assisted Reproduction and Genetics, Vol. 40 No. 5, pp. 955-67.
Asherman, J. G. (1948), “Amenorrhoea Traumatica (Atretica)”, Journal of Obstetrics and Gynaecology, Vol. 55 No. 1, pp. 23-30.
Benor, A., Gay, S. and DeCherney, A. (2020), “An update on stem cell therapy for Asherman syndrome”, Journal of Assisted Reproduction and Genetics, Vol. 37 No. 7, pp. 1511-29.
Bianconi, E., Piovesan, A., Facchin, F., Beraudi, A., Casadei, R., Frabetti, F., Vitale, L., Pelleri, M. C., Tassani, S., Piva, F., Perez-Amodio, S., Strippoli, P. and Canaider, S. (2013), “An estimation of the number of cells in the human body”, Annals of Human Biology,Vol. 40 No. 6, pp. 463-71.
Cen, J., Zhang, Y., Bai, Y., Ma, S., Zhang, C., Jin, L., Duan, S., Du, Y. and Guo, Y. (2022), “Research progress of stem cell therapy for endometrial injury”, Materials Today Bio, Vol. 16.
Chaiworapongsa, T., Chaemsaithong, P., Yeo, L. and Romero, R. (2014), “Pre-eclampsia part 1: current understanding of its pathophysiology”, Nature Reviews Nephrology, Vol. 10 No. 8, pp. 466-80.
Dahiphale, S. M., Potdar, J., Acharya, N., Jyotsna, G., Saloni, and Desale, R. (2024), “Congenital Anomalies of the Female Genital Tract: A Comprehensive Review”, 16 No. 3, pp. e56753.
Dai, F., Wang, R., Deng, Z., Yang, D., Wang, L., Wu, M., Hu, W. and Cheng, Y. (2023), “Comparison of the diferent animal modeling and therapy methods of premature ovarian failure in animal model”, Stem Cell Research and Therapy, Vol. 14 No. 1, pp. 135.
Ding, D., Shyu, W. and Lin, S. (2011), “Mesenchymal Stem Cells”, Cell Transplantation, Vol. 20 No. 1, pp. 5-14.
Esfandyari, S., Chugh, R. M., Park, H., Hobeika, E., Ulin, M. and Al-Hendy, A. (2020), “Mesenchymal Stem Cells as a Bio Organ for Treatment of Female Infertility”, Cells, Vol. 9 No. 10, pp. 2253.
Fu, Y., Ji, J., Shan, F., Li, J. and Rong, H. (2021), “Human mesenchymal stem cell treatment of premature ovarian failure: new challenges and opportunities”, Stem Cell Research and Therapy, Vol. 12 No. 1, pp. 161.
Galipeau, J. and Sensébé, L. (2018), “Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities”, Cell Stem Cell, Vol. 22 No. 6, pp. 824-33.
Gurung, S., Williams, S., Deane, J. A., Werkmeister, J. A. and Gargett, C. E. (2018), “The Transcriptome of Human Endometrial Mesenchymal Stem Cells Under TGFβR Inhibition Reveals Improved Potential for Cell-Based Therapies”, Frontiers in Cell and Developmental Biology, Vol. 6, pp. 164.
Hoang, D. M., Pham, P. T., Bach, T. Q., Ngo, A. T. L., Nguyen, Q. T., Phan, T. T. K., Nguyen, G. H., Le, P. T. T., Hoang, V. T., Forsyth, N. R., Heke, M. and Nguyen, L. T. (2022), “Stem cell-based therapy for human diseases”, Signal Transduction and Targeted Therapy, Vol. 7 No. 1, pp. 272.
Ivkošic, I. E., Fureš, R., Ćosić, V., Mikelin, N., Bulić, L., Dobranić, D., Brlek, P. and Primorac, D. (2023), “Unlocking the Potential of Mesenchymal Stem Cells in Gynecology: Where Are We Now?”, Journal of Personalized Medicine, Vol. 13 No. 8, pp. 1253.
Jin, S., Wu, C., Chen, M., Sun, D. and Zhang, H. (2022), “The pathological and therapeutic roles of mesenchymal stem cells in preeclampsia”, Frontiers in Medicine, Vol. 9.
Liao, Z., Liu, C., Wang, L., Sui, C. and Zhang, H. (2021), “Therapeutic Role of Mesenchymal Stem Cell-Derived Extracellular Vesicles in Female Reproductive Diseases”, Frontiers in Endocrinology, Vol. 12.
Liu, X., Li, J., Wang, W., Ren, X. and Hu, J. (2023), “Therapeutic restoration of female reproductive and endocrine dysfunction using stem cells”, Life Sciences, Vol. 322.
Mutlu, L., Hufnagel, D. and Taylor, H. S. (2015), “The Endometrium as a Source of Mesenchymal Stem Cells for Regenerative Medicine”, Biology of Reproduction, Vol. 92 No. 6, pp. 1-11.
Naji, A., Rouas-Freiss, N., Durrbach, A., Carosella, E. D., Sensébé, L. and Deschaseaux, F. (2013), “Concise review: combining human leukocyte antigen G and mesenchymal stem cells for immunosuppressant biotherapy”, Stem Cells, Vol. 31 No. 11, pp. 2296-303.
Prayitno, G. D., Lestari, K., Sartika, C. R., Djuwantono, T., Widjaya, A., Muharam, R., Hidayat, Y. M., Wulandari, D., Haifa, R., Naura, N. F., Marbun, K. T. and Zahrah, A. (2022), “Potential of Mesenchymal Stem Cells and Their Secretomes in Decreasing Inflammation Markers in Polycystic Ovary Syndrome Treatment: A Systematic Review”, Medicines, Vol. 10, No. 1.
Shareghi-Oskoue, O., Aghebati-Maleki, L. and Yousefi, M. (2021), “Transplantation of human umbilical cord mesenchymal stem cells to treat premature ovarian failure”, Stem Cell Research and Therapy, Vol. 12 No. 1, pp. 454.
Squillaro, T., Peluso, G. and Galderisi, U. (2016), “Clinical Trials With Mesenchymal Stem Cells: An Update”, Cell Transplantation, Vol. 25 No. 5, pp. 829-48.
Taylor, H., Pal, L., and Seli, E. (2019), “Speroff’s Clinical Gynecologic Endocrinology and Infertility, 9th ed”, Lippincott Williams & Wilkins: Philadelphia, PA, USA.
Ullah, I., Subbarao, R. B. and Rho, G. J. (2015), “Human mesenchymal stem cells - current trends and future prospective”, Bioscience Reports, Vol. 35 No. 2, pp. e00191.
Yang, J. and Huang, F. (2014), “Stem cell and endometriosis: new knowledge may be producing novel therapies”, International Journal of Clinical and Experimental Medicine, Vol. 7 No. 11, pp. 3853-8.
Zhang, S., Mao, Y., Zhao, X., Zhang, H., Ma, M., Long, X. and Wang, S. (2021), “Intrauterine Adhesions (IUAs) or Asherman’s Syndrome (AS) and the Stem Cells Treatment: A Systemic Review and Meta-Analysis”, Journal of Biosciences and Medicines, Vol. 9 No. 1, pp. 105-18.
Zhang, Y., Shi, L., Lin, X., Zhou, F., Xin, L., Xu, W., Yu, H., Li, J., Pan, M., Pan, Y., Dai, Y., Zhang, Y., Shen, J., Zhao, L., Lu, M. and Zhang, S. (2021), “Unresponsive thin endometrium caused by Asherman syndrome treated with umbilical cord mesenchymal stem cells on collagen scaffolds: a pilot study”, Stem Cell Research and Therapy, Vol. 12.
Zhao, Y., Chen, S., Su, P., Huang, F., Shi, Y., Shi, Q. and Lin, S. (2019), “Using Mesenchymal Stem Cells to Treat Female Infertility: An Update on Female derived exosomes inhibit ovarian granulosa cells inflammatory response through inhibition of NF-κB signaling in polycystic ovary syndrome”, Journal of Reproductive Immunology, Vol. 152.
Zhao, Y., Pan, S. and Wu, X. (2022), “Human umbilical cord mesenchymal stem cell- Reproductive Diseases”, Stem Cells International, Vol. 2019.
Copyright (c) 2024 Journal of Stem Cell Research and Tissue Engineering
This work is licensed under a Creative Commons Attribution 4.0 International License.
1. As an author you (or your employer or institution) may do the following:
- make copies (print or electronic) of the article for your own personal use, including for your own classroom teaching use;
- make copies and distribute such copies (including through e-mail) of the article to research colleagues, for the personal use by such colleagues (but not commercially or systematically, e.g. via an e-mail list or list server);
- present the article at a meeting or conference and to distribute copies of the article to the delegates attending such meeting;
- for your employer, if the article is a ‘work for hire', made within the scope of your employment, your employer may use all or part of the information in the article for other intra-company use (e.g. training);
- retain patent and trademark rights and rights to any process, procedure, or article of manufacture described in the article;
- include the article in full or in part in a thesis or dissertation (provided that this is not to be published commercially);
- use the article or any part thereof in a printed compilation of your works, such as collected writings or lecture notes (subsequent to publication of the article in the journal); and prepare other derivative works, to extend the article into book-length form, or to otherwise re-use portions or excerpts in other works, with full acknowledgement of its original publication in the journal;
- may reproduce or authorize others to reproduce the article, material extracted from the article, or derivative works for the author's personal use or for company use, provided that the source and the copyright notice are indicated, the copies are not used in any way that implies JSCRTE endorsement of a product or service of any employer, and the copies themselves are not offered for sale.
All copies, print or electronic, or other use of the paper or article must include the appropriate bibliographic citation for the article's publication in the journal.
2. Requests from third parties
Although authors are permitted to re-use all or portions of the article in other works, this does not include granting third-party requests for reprinting, republishing, or other types of re-use. Requests for all uses not included above, including the authorization of third parties to reproduce or otherwise use all or part of the article (including figures and tables), should be referred to JSCRTE by going to our website at http://e-journal.unair.ac.id/index.php/JSCRTE
3. Author Online Use
- Personal Servers. Authors and/or their employers shall have the right to post the accepted version of articles pre-print version of the article, or revised personal version of the final text of the article (to reflect changes made in the peer review and editing process) on their own personal servers or the servers of their institutions or employers without permission from JSCRTE, provided that the posted version includes a prominently displayed JSCRTE copyright notice and, when published, a full citation to the original publication, including a link to the article abstract in the journal homepage. Authors shall not post the final, published versions of their papers;
- Classroom or Internal Training Use. An author is expressly permitted to post any portion of the accepted version of his/her own articles on the author's personal web site or the servers of the author's institution or company in connection with the author's teaching, training, or work responsibilities, provided that the appropriate copyright, credit, and reuse notices appear prominently with the posted material. Examples of permitted uses are lecture materials, course packs, e-reserves, conference presentations, or in-house training courses;
- Electronic Preprints. Before submitting an article to an JSCRTE, authors frequently post their manuscripts to their own web site, their employer's site, or to another server that invites constructive comment from colleagues. Upon submission of an article to JSCRTE, an author is required to transfer copyright in the article to JSCRTE, and the author must update any previously posted version of the article with a prominently displayed JSCRTE copyright notice. Upon publication of an article by the JSCRTE, the author must replace any previously posted electronic versions of the article with either (1) the full citation to the work with a Digital Object Identifier (DOI) or link to the article abstract in JSCRTE homepage, or (2) the accepted version only (not the final, published version), including the JSCRTE copyright notice and full citation, with a link to the final, published article in journal homepage.
4. Articles in Press (AiP) service
JSCRTE may choose to publish an abstract or portions of the paper before we publish it in the journal. Please contact our Production department immediately if you do not want us to make any such prior publication for any reason, including disclosure of a patentable invention.
5. Author/Employer Rights
If you are employed and prepared the article on a subject within the scope of your employment, the copyright in the article belongs to your employer as a work-for-hire. In that case, JSCRTE assumes that when you sign this Form, you are authorized to do so by your employer and that your employer has consented to the transfer of copyright, to the representation and warranty of publication rights, and to all other terms and conditions of this Form. If such authorization and consent has not been given to you, an authorized representative of your employer should sign this Form as the Author.
6. JSCRTE Copyright Ownership
It is the formal policy of JSCRTE to own the copyrights to all copyrightable material in its technical publications and to the individual contributions contained therein, in order to protect the interests of the JSCRTE, its authors and their employers, and, at the same time, to facilitate the appropriate re-use of this material by others. JSCRTE distributes its technical publications throughout the world and does so by various means such as hard copy, microfiche, microfilm, and electronic media. It also abstracts and may translate its publications, and articles contained therein, for inclusion in various compendiums, collective works, databases and similar publications
Every accepted manuscript should be accompanied by "Copyright Transfer Agreement" prior to the article publication.
